PMID- 24801510 OWN - NLM STAT- MEDLINE DCOM- 20140729 LR - 20140819 IS - 1552-5783 (Electronic) IS - 0146-0404 (Linking) VI - 55 IP - 6 DP - 2014 May 6 TI - Topographic localization of macular retinal ganglion cell loss associated with localized peripapillary retinal nerve fiber layer defect. PG - 3501-8 LID - 10.1167/iovs.14-13925 [doi] AB - PURPOSE: To investigate the topographic relationship between ganglion cell-inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (pRNFL) defects in open-angle glaucoma patients with localized RNFL defects, using spectral-domain optical coherence tomography (SD-OCT). METHODS: We analyzed 140 eyes of 140 patients showing a localized RNFL defect in one hemifield, the angular width of which was limited to one clock-hour sector. The RNFL and macular GCIPL scans were obtained using SD-OCT. The clock-hour location and width of pRNFL defects on the RNFL deviation map were determined, and their topographic association with corresponding GCIPL defects on the GCIPL deviation map was assessed. RESULTS: A "GCIPL deviation frequency map" demonstrating GCIPL defects corresponding to six different clock-hour locations of pRNFL defects was obtained, and it revealed the following specifics: (1) pRNFL defect at 12, 11, and 10 o'clock corresponded to GCIPL defect in the superior macula, as those at 8, 7, and 6 o'clock did to those in the inferior macula; (2) the overall GCIPL defect had an arcuate shape that appeared as a continuation of the pRNFL defect; (3) the temporal macular region was the frequently damaged site in either hemifield, and was larger in the inferior hemifield than in the superior hemifield. Additionally, an interindividual variability of GCIPL defect was noted for patients with the same clock-hour location of pRNFL defect. CONCLUSIONS: The GCIPL deviation frequency map demonstrating the topographic relationship between pRNFL and GCIPL defects was generated using SD-OCT. Our results indicated the topographic location of retinal ganglion cell death associated with clock-hour location of pRNFL loss in vivo. CI - Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc. FAU - Kim, Ko Eun AU - Kim KE AD - Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea. FAU - Park, Ki Ho AU - Park KH AD - Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea. FAU - Yoo, Beong Wook AU - Yoo BW AD - Interdisciplinary Program, Bioengineering Major, Graduate School, Seoul National University, Seoul, Korea. FAU - Jeoung, Jin Wook AU - Jeoung JW AD - Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea. FAU - Kim, Dong Myung AU - Kim DM AD - Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea. FAU - Kim, Hee Chan AU - Kim HC AD - Department of Biomedical Engineering, College of Medicine and Institute of Medical and Biological Engineering, Medical Research Center, Seoul National University, Seoul, Korea. LA - eng PT - Journal Article DEP - 20140506 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 SB - IM MH - Female MH - Follow-Up Studies MH - Glaucoma, Open-Angle/complications/*pathology/physiopathology MH - Humans MH - Macula Lutea/*pathology MH - Male MH - Middle Aged MH - Nerve Fibers/*pathology MH - ROC Curve MH - Retinal Diseases/etiology/*pathology MH - Retinal Ganglion Cells/*pathology MH - Retrospective Studies MH - Tomography, Optical Coherence/*methods OTO - NOTNLM OT - ganglion cell-inner plexiform layer defect OT - peripapillary retinal nerve fiber layer defect OT - spectral-domain optical coherence tomography OT - topographic relationship EDAT- 2014/05/08 06:00 MHDA- 2014/07/30 06:00 CRDT- 2014/05/08 06:00 PHST- 2014/05/08 06:00 [entrez] PHST- 2014/05/08 06:00 [pubmed] PHST- 2014/07/30 06:00 [medline] AID - iovs.14-13925 [pii] AID - 10.1167/iovs.14-13925 [doi] PST - epublish SO - Invest Ophthalmol Vis Sci. 2014 May 6;55(6):3501-8. doi: 10.1167/iovs.14-13925.